Tanupriya Agrawal1, Gaurav K Gupta, Devendra K Agrawal. 1. Department of Biomedical Sciences and Center for Clinical & Translational Science, Creighton University School of Medicine, Omaha, NE 68178, USA.
Abstract
AIMS: Asthma is one of the most common chronic inflammatory diseases of the airways. Calcitriol exerts its action through Vitamin D receptor (VDR), which is a high affinity nuclear receptor. VDR is a transcription factor that alters the transcription of target genes which are involved in a wide spectrum of biological responses. Lower serum vitamin D levels are associated with airway hyperresponsiveness and increased asthma severity. Prohibitin is a ubiquitously expressed protein localized to the cell and mitochondrial membranes and the nucleus. METHODS AND RESULTS: HBSMCs were cultured and treated with calcitriol and/or TNF-α. The mRNA and protein expression of prohibitin and VDR were analyzed using qPCR and immunoblotting, respectively. In the in vivo studies, female BALB/c mice were fed with special vitamin D-deficient or 2000IU/kg of vitamin D-supplemented diet for 13weeks. Mouse model of allergic airway inflammation was developed by OVA-sensitization and challenge. The expression pattern of TNF-α, prohibitin and VDR in the lung of OVA-sensitized mice was analyzed using immunofluorescence. Calcitriol significantly increased and TNF-α decreased the protein and mRNA expression of prohibitin and VDR in HBSMCs. There was significantly increased expression of TNF-α and decreased expression of VDR and prohibitin in the lung of vitamin D-deficient mouse model of allergic airway inflammation. CONCLUSION: These results suggest that under inflammatory conditions there is decreased expression of VDR resulting in decreased expression of prohibitin, which is a vitamin D target gene. Vitamin D deficiency causes increase in the expression of TNF-α, thereby increasing inflammation and decreases the expression of VDR and prohibitin. Supplementation with vitamin D might reduce the levels of TNF-α, thereby increasing the expression of VDR and prohibitin that could be responsible for reducing allergic airway inflammation.
AIMS: Asthma is one of the most common chronic inflammatory diseases of the airways. Calcitriol exerts its action through Vitamin D receptor (VDR), which is a high affinity nuclear receptor. VDR is a transcription factor that alters the transcription of target genes which are involved in a wide spectrum of biological responses. Lower serum vitamin D levels are associated with airway hyperresponsiveness and increased asthma severity. Prohibitin is a ubiquitously expressed protein localized to the cell and mitochondrial membranes and the nucleus. METHODS AND RESULTS: HBSMCs were cultured and treated with calcitriol and/or TNF-α. The mRNA and protein expression of prohibitin and VDR were analyzed using qPCR and immunoblotting, respectively. In the in vivo studies, female BALB/c mice were fed with special vitamin D-deficient or 2000IU/kg of vitamin D-supplemented diet for 13weeks. Mouse model of allergic airway inflammation was developed by OVA-sensitization and challenge. The expression pattern of TNF-α, prohibitin and VDR in the lung of OVA-sensitized mice was analyzed using immunofluorescence. Calcitriol significantly increased and TNF-α decreased the protein and mRNA expression of prohibitin and VDR in HBSMCs. There was significantly increased expression of TNF-α and decreased expression of VDR and prohibitin in the lung of vitamin D-deficient mouse model of allergic airway inflammation. CONCLUSION: These results suggest that under inflammatory conditions there is decreased expression of VDR resulting in decreased expression of prohibitin, which is a vitamin D target gene. Vitamin D deficiency causes increase in the expression of TNF-α, thereby increasing inflammation and decreases the expression of VDR and prohibitin. Supplementation with vitamin D might reduce the levels of TNF-α, thereby increasing the expression of VDR and prohibitin that could be responsible for reducing allergic airway inflammation.
Authors: Arianne L Theiss; Richard D Idell; Shanthi Srinivasan; Jan-Michael Klapproth; Dean P Jones; Didier Merlin; Shanthi V Sitaraman Journal: FASEB J Date: 2006-11-29 Impact factor: 5.191
Authors: John M Brehm; Juan C Celedón; Manuel E Soto-Quiros; Lydiana Avila; Gary M Hunninghake; Erick Forno; Daniel Laskey; Jody S Sylvia; Bruce W Hollis; Scott T Weiss; Augusto A Litonjua Journal: Am J Respir Crit Care Med Date: 2009-01-29 Impact factor: 21.405
Authors: Mike A Berry; Beverley Hargadon; Maria Shelley; Debbie Parker; Dominick E Shaw; Ruth H Green; Peter Bradding; Christopher E Brightling; Andrew J Wardlaw; Ian D Pavord Journal: N Engl J Med Date: 2006-02-16 Impact factor: 91.245
Authors: Arianne L Theiss; Matam Vijay-Kumar; Tracy S Obertone; Dean P Jones; Jason M Hansen; Andrew T Gewirtz; Didier Merlin; Shanthi V Sitaraman Journal: Gastroenterology Date: 2009-03-25 Impact factor: 22.682
Authors: Rodney D Britt; Arij Faksh; Elizabeth Vogel; Richard J Martin; Christina M Pabelick; Y S Prakash Journal: Expert Rev Respir Med Date: 2013-10-03 Impact factor: 3.772
Authors: Shelley Gorman; Clare E Weeden; Daryl H W Tan; Naomi M Scott; Julie Hart; Rachel E Foong; Danny Mok; Nahiid Stephens; Graeme Zosky; Prue H Hart Journal: PLoS One Date: 2013-06-24 Impact factor: 3.240